<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font19 { font-size : 19; } .font24 { font-size : 24; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font29">the </span>
   <span class="font24">with </span>
   <span class="font19">patients </span>
   <span class="font16">COVID- </span>
   <span class="font15">[]. </span>
   <span class="font15">for </span>
   <span class="font14">severe </span>
   <span class="font13">that </span>
   <span class="font13">this </span>
   <span class="font13">anticoagulation </span>
   <span class="font13">respiratory </span>
   <span class="font13">{background </span>
   <span class="font12">are </span>
   <span class="font12">disease </span>
   <span class="font12">The </span>
   <span class="font12">study </span>
   <span class="font12">thrombosis </span>
   <span class="font12">been </span>
   <span class="font12">has </span>
   <span class="font12">have </span>
   <span class="font12">margin </span>
   <span class="font12">therapeutic </span>
   <span class="font12">{border-style </span>
   <span class="font11">NCT </span>
   <span class="font11">pulmonary </span>
   <span class="font11">coronavirus </span>
   <span class="font11">immune </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">RCT </span>
   <span class="font11">clinical </span>
   <span class="font11">prophylactic </span>
   <span class="font11">was </span>
   <span class="font11">were </span>
   <span class="font11">days </span>
   <span class="font11">dose </span>
   <span class="font11">heparin </span>
   <span class="font11">infection </span>
   <span class="font11">trials </span>
   <span class="font11">which </span>
   <span class="font11">not </span>
   <span class="font11">will </span>
   <span class="font11">acute </span>
   <span class="font11">from </span>
   <span class="font11">mortality </span>
   <span class="font11">vs. </span>
   <span class="font11">This </span>
   <span class="font11">inflammatory </span>
   <span class="font11">risk </span>
   <span class="font11">syndrome </span>
   <span class="font11">Anticoagulation </span>
   <span class="font11">disease, </span>
   <span class="font11">failure </span>
   <span class="font11">high </span>
   <span class="font11">lung </span>
   <span class="font11">other </span>
   <span class="font11">prophylaxis </span>
   <span class="font11">used </span>
   <span class="font11">ICU </span>
   <span class="font11">Thromb </span>
   <span class="font11">also </span>
   <span class="font11">anti-inflammatory </span>
   <span class="font11">associated </span>
   <span class="font11">cell </span>
   <span class="font11">cells </span>
   <span class="font11">coagulation </span>
   <span class="font11">combination </span>
   <span class="font11">these </span>
   <span class="font11">virus </span>
   <span class="font11">IL, </span>
   <span class="font11">Trial </span>
   <span class="font11">any </span>
   <span class="font11">but </span>
   <span class="font11">drugs </span>
   <span class="font11">some </span>
   <span class="font11">system </span>
   <span class="font11">there </span>
   <span class="font11">those </span>
   <span class="font10">USA </span>
   <span class="font10">agents </span>
   <span class="font10">factor </span>
   <span class="font10">found </span>
   <span class="font10">incidence </span>
   <span class="font10">may </span>
   <span class="font10">microvascular </span>
   <span class="font10">novel </span>
   <span class="font10">therapy </span>
   <span class="font10">type </span>
   <span class="font10">use </span>
   <span class="font10">viral </span>
   <span class="font10">Hospital, </span>
   <span class="font10">care </span>
   <span class="font10">cytokine </span>
   <span class="font10">disease. </span>
   <span class="font10">enoxaparin </span>
   <span class="font10">evidence </span>
   <span class="font10">ill </span>
   <span class="font10">increased </span>
   <span class="font10">low </span>
   <span class="font10">patients, </span>
   <span class="font10">protein </span>
   <span class="font10">px; </span>
   <span class="font10">severity </span>
   <span class="font10">thrombotic </span>
   <span class="font10">{font-family </span>
   <span class="font10">Haemost../jth. </span>
   <span class="font10">SOC </span>
   <span class="font10">activation </span>
   <span class="font10">can </span>
   <span class="font10">critically </span>
   <span class="font10">currently </span>
   <span class="font10">dysregulation </span>
   <span class="font10">features </span>
   <span class="font10">font-size </span>
   <span class="font10">higher </span>
   <span class="font10">hospitalized </span>
   <span class="font10">intensive </span>
   <span class="font10">lower </span>
   <span class="font10">outcomes </span>
   <span class="font10">review </span>
   <span class="font10">showed </span>
   <span class="font10">significant </span>
   <span class="font10">studies </span>
   <span class="font10">(e.g., </span>
   <span class="font10">ACE </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Multiple </span>
   <span class="font10">NCT, </span>
   <span class="font10">These </span>
   <span class="font10">adaptive </span>
   <span class="font10">admitted </span>
   <span class="font10">all </span>
   <span class="font10">all-cause </span>
   <span class="font10">approach </span>
   <span class="font10">chronic </span>
   <span class="font10">complement </span>
   <span class="font10">double; </span>
   <span class="font10">due </span>
   <span class="font10">effective </span>
   <span class="font10">group </span>
   <span class="font10">inflammation </span>
   <span class="font10">innate </span>
   <span class="font10">interferon </span>
   <span class="font10">likely </span>
   <span class="font10">most </span>
   <span class="font10">patients. </span>
   <span class="font10">plasma </span>
   <span class="font10">standard </span>
   <span class="font10">strategy </span>
   <span class="font10">time </span>
   <span class="font10">trial </span>
   <span class="font10">vascular </span>
   <span class="font10">within </span>
   <span class="font10">Any </span>
   <span class="font10">April </span>
   <span class="font10">COVID-J </span>
   <span class="font10">Care </span>
   <span class="font10">However, </span>
   <span class="font10">Patients </span>
   <span class="font10">Therapy </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">admission </span>
   <span class="font10">another </span>
   <span class="font10">article </span>
   <span class="font10">being </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cases </span>
   <span class="font10">centers, </span>
   <span class="font10">deep </span>
   <span class="font10">distress </span>
   <span class="font10">efficacy </span>
   <span class="font10">elevated </span>
   <span class="font10">embolism </span>
   <span class="font10">endothelial </span>
   <span class="font10">enzyme </span>
   <span class="font10">findings </span>
   <span class="font10">hypercoagulability </span>
   <span class="font10">ibuprofen </span>
   <span class="font10">infected </span>
   <span class="font10">injury </span>
   <span class="font10">intermediate </span>
   <span class="font10">levels </span>
   <span class="font10">macrophage </span>
   <span class="font10">major </span>
   <span class="font10">number </span>
   <span class="font10">pneumonia </span>
   <span class="font10">rate </span>
   <span class="font10">recognized </span>
   <span class="font10">results </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">suppression </span>
   <span class="font10">systemic </span>
   <span class="font10">tocilizumab </span>
   <span class="font10">treatment </span>
   <span class="font10">vein </span>
   <span class="font10">ventilation </span>
   <span class="font10">well </span>
   <span class="font10">who </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(%) </span>
   <span class="font10">(Fig.Â </span>
   <span class="font10">All-cause </span>
   <span class="font10">Another </span>
   <span class="font10">China: </span>
   <span class="font10">Clinical </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">D-dimer </span>
   <span class="font10">DIC </span>
   <span class="font10">Immune </span>
   <span class="font10">Infect </span>
   <span class="font10">Medical </span>
   <span class="font10">Randomized </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">TNFÎ± </span>
   <span class="font10">Therapeutic </span>
   <span class="font10">There </span>
   <span class="font10">Versus </span>
   <span class="font10">against </span>
   <span class="font10">al.Clinical </span>
   <span class="font10">alveolar </span>
   <span class="font10">analysis </span>
   <span class="font10">angiotensin-converting </span>
   <span class="font10">anticoagulation, </span>
   <span class="font10">antiviral, </span>
   <span class="font10">appears </span>
   <span class="font10">available </span>
   <span class="font10">baricitinib, </span>
   <span class="font10">before </span>
   <span class="font10">between </span>
   <span class="font10">bleeding </span>
   <span class="font10">bold </span>
   <span class="font10">cause </span>
   <span class="font10">caused </span>
   <span class="font10">cells, </span>
   <span class="font10">changes </span>
   <span class="font10">combined </span>
   <span class="font10">compared </span>
   <span class="font10">complications </span>
   <span class="font10">conducted </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">death </span>
   <span class="font10">direct </span>
   <span class="font10">em; </span>
   <span class="font10">endotheliitis </span>
   <span class="font10">extracellular </span>
   <span class="font10">failure. </span>
   <span class="font10">had </span>
   <span class="font10">help </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibition </span>
   <span class="font10">intermediate-dose </span>
   <span class="font10">invasive </span>
   <span class="font10">its </span>
   <span class="font10">laboratory </span>
   <span class="font10">lactate </span>
   <span class="font10">leads </span>
   <span class="font10">like </span>
   <span class="font10">molecular </span>
   <span class="font10">new </span>
   <span class="font10">noted </span>
   <span class="font10">one </span>
   <span class="font10">ongoing </span>
   <span class="font10">only </span>
   <span class="font10">oxygen </span>
   <span class="font10">parameters </span>
   <span class="font10">pathways </span>
   <span class="font10">protease </span>
   <span class="font10">pt;} </span>
   <span class="font10">response </span>
   <span class="font10">responses </span>
   <span class="font10">seen </span>
   <span class="font10">should </span>
   <span class="font10">state </span>
   <span class="font10">study, </span>
   <span class="font10">suggest </span>
   <span class="font10">suggesting </span>
   <span class="font10">target </span>
   <span class="font10">thrombosis, </span>
   <span class="font10">treating </span>
   <span class="font10">unique </span>
   <span class="font10">using </span>
   <span class="font10">weight </span>
   <span class="font10">when </span>
  </p>
 </body>
</html>
